IL18 and Miyoshi myopathy: Analyzing the expression of CD25 receptor we show that both percentage and MFI of this receptor increase significantly (p < 0.05, Wilcoxon signed rank test) on NK cells and their dim and bright subsets in HC and MM patients after 18 h in vitro treatment with IL-12 and IL-18 in combination.